These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 29908134)

  • 1. [Crystal structure and crystal form stability of trelagliptin succinate].
    Ye JL; Zhou XB; Wu SX; Sun MY; Gu JM; Hu XR
    Yao Xue Xue Bao; 2016 Nov; 51(11):1759-64. PubMed ID: 29908134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystal forms of the hydrogen oxalate salt of o-desmethylvenlafaxine.
    Dichiarante E; Curzi M; Giaffreda SL; Grepioni F; Maini L; Braga D
    J Pharm Pharmacol; 2015 Jun; 67(6):823-9. PubMed ID: 25644936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a validated HPLC method for the quantitative determination of trelagliptin succinate and its related substances in pharmaceutical dosage forms.
    Luo Z; Chen X; Wang G; Du Z; Ma X; Wang H; Yu G; Liu A; Li M; Peng W; Liu Y
    Eur J Pharm Sci; 2018 Jan; 111():458-464. PubMed ID: 29066384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel polymorph of ambrisentan: Characterization and stability.
    Haneef J; Chadha R; Gupta V; Mandal SK
    J Pharm Biomed Anal; 2018 May; 153():102-109. PubMed ID: 29475138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calorimetric and diffractometric evidence for the sequential crystallization of buffer components and the consequential pH swing in frozen solutions.
    Sundaramurthi P; Shalaev E; Suryanarayanan R
    J Phys Chem B; 2010 Apr; 114(14):4915-23. PubMed ID: 20302316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of crystal morphology and mill type on milling induced crystal disorder.
    Chikhalia V; Forbes RT; Storey RA; Ticehurst M
    Eur J Pharm Sci; 2006 Jan; 27(1):19-26. PubMed ID: 16246535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural Properties, Order-Disorder Phenomena, and Phase Stability of Orotic Acid Crystal Forms.
    Braun DE; Nartowski KP; Khimyak YZ; Morris KR; Byrn SR; Griesser UJ
    Mol Pharm; 2016 Mar; 13(3):1012-29. PubMed ID: 26741914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystal Structure Analysis of the First Discovered Stability-Enhanced Solid State of Tenofovir Disoproxil Free Base Using Single Crystal X-ray Diffraction.
    An JH; Kiyonga AN; Yoon W; Ryu HC; Kim JS; Kang C; Park M; Yun H; Jung K
    Molecules; 2017 Jul; 22(7):. PubMed ID: 28708115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of solvents and crystallization conditions on the polymorphic behaviors and dissolution rates of valsartan.
    Tran TT; Tran PH; Park JB; Lee BJ
    Arch Pharm Res; 2012 Jul; 35(7):1223-30. PubMed ID: 22864745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation on growth, structure and characterization of succinate salt of 8-hydroxyquinoline: an organic NLO crystal.
    Thirumurugan R; Babu B; Anitha K; Chandrasekaran J
    Spectrochim Acta A Mol Biomol Spectrosc; 2015 Apr; 140():44-53. PubMed ID: 25589396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystal form of cephradine.
    Sohn YT; Park SH
    Arch Pharm Res; 2006 Feb; 29(2):178-82. PubMed ID: 16526284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal forms of atorvastatin.
    An SG; Sohn YT
    Arch Pharm Res; 2009 Jun; 32(6):933-6. PubMed ID: 19557372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystal modification of dipyridamole using different solvents and crystallization conditions.
    Adhiyaman R; Basu SK
    Int J Pharm; 2006 Sep; 321(1-2):27-34. PubMed ID: 16842943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solubilization and solid-state characterization of a poorly soluble 5-alpha reductase inhibitor.
    Zhu HJ; Sacchetti M
    Drug Dev Ind Pharm; 2004 Jul; 30(6):573-80. PubMed ID: 15285330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Polymorphism of shikimic acid].
    Wang FF; Yang DZ; Lv Y
    Zhongguo Zhong Yao Za Zhi; 2016 Aug; 41(15):2861-2863. PubMed ID: 28914029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Investigation into the Polymorphism and Crystallization of Levetiracetam and the Stability of its Solid Form.
    Xu K; Xiong X; Guo L; Wang L; Li S; Tang P; Yan J; Wu D; Li H
    J Pharm Sci; 2015 Dec; 104(12):4123-4131. PubMed ID: 26331706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of the solid-dispersion method on the solubility and crystalline property of tacrolimus.
    Joe JH; Lee WM; Park YJ; Joe KH; Oh DH; Seo YG; Woo JS; Yong CS; Choi HG
    Int J Pharm; 2010 Aug; 395(1-2):161-6. PubMed ID: 20580799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solid state characterization of azelnidipine-oxalic acid co-crystal and co-amorphous complexes: The effect of different azelnidipine polymorphs.
    Pan Y; Pang W; Lv J; Wang J; Yang C; Guo W
    J Pharm Biomed Anal; 2017 May; 138():302-315. PubMed ID: 28237872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystal forms of naproxen.
    Song JS; Sohn YT
    Arch Pharm Res; 2011 Jan; 34(1):87-90. PubMed ID: 21468919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New solvates of an old drug compound (phenobarbital): structure and stability.
    Zencirci N; Griesser UJ; Gelbrich T; Kahlenberg V; Jetti RK; Apperley DC; Harris RK
    J Phys Chem B; 2014 Mar; 118(12):3267-80. PubMed ID: 24571055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.